LaBarre Michael J.

CIK 00015071741 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001507174

Recent Transactions

50 trades

Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-27$58.25/sh−1,597→ 173,856 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-27$58.74/sh−100→ 173,756 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-26$58.09/sh−9,400→ 176,053 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-26$58.65/sh−600→ 175,453 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-25$58.67/sh−700→ 185,453 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-25$58.01/sh−9,300→ 186,153 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-23$57.75/sh−2,410→ 195,453 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-23−4,747→ 14,238 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-23+4,747→ 197,863 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-02-20+11,902→ 11,902 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-20+11,230→ 11,230 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-16−6,112→ 6,112 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16$58.29/sh−2,164→ 193,116 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16+20,891→ 196,729 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16+6,112→ 194,120 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16$58.29/sh−8,721→ 188,008 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16+4,263→ 195,280 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16$58.29/sh−3,103→ 191,017 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-16−4,263→ 8,526 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-02-16−20,891→ 0 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-15−3,386→ 0 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-15$58.29/sh−1,304→ 175,838 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-15+3,386→ 177,142 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-02-12+7,262→ 20,891 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Unit
2025-02-12+4,921→ 4,921 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-02-12+20,342→ 20,342 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-02-12+4,177→ 6,547 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-10-16−10,000→ 26,608 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-10-16$53.26/sh−10,000→ 173,756 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-10-16$19.98/sh+10,000→ 183,756 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-10-15$16.65/sh+5,509→ 179,265 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-10-15$19.98/sh+4,491→ 183,756 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-10-15$54.24/sh−77→ 173,756 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-10-15$53.74/sh−9,923→ 173,833 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-10-15−5,509→ 6,352 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-10-15−4,491→ 36,608 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-09-18$62.58/sh−2,037→ 173,756 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-09-18$16.65/sh+10,000→ 183,756 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-09-18−10,000→ 11,861 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-09-18$61.89/sh−7,963→ 175,793 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-09-17$16.65/sh+10,000→ 183,756 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-09-17$62.88/sh−10,000→ 173,756 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-09-17−10,000→ 21,861 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-08-27−5,580→ 0 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-08-27$18.41/sh+5,580→ 173,756 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-08-21$62.34/sh−100→ 168,176 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-08-21−10,000→ 31,861 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-08-21$61.74/sh−9,900→ 168,276 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-08-21$16.65/sh+10,000→ 178,176 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-08-20$16.65/sh+10,000→ 178,176 total

Companies

HALOZYME THERAPEUTICS, INC.
VP, Product Development
$HALO

Recent Filings

Address

11388 SORRENTO VALLEY ROAD

SAN DIEGO, CA, 92121

View on SEC.gov